Short answer
Glutathione draws 14,800 searches a month in Poland against 246,000 in the US (Google Ads Keyword Planner, average monthly searches, October 2025 - September 2026), an index of 0.54 per head. Before launching, confirm its novel food status for your exact form: glutathione had no entry in the Union list of novel foods as first adopted in 2017, and S-acetyl glutathione was still under EFSA assessment as a novel food in mid-2026. We found no authorised health claim for glutathione, so the label cannot promise skin, detox or antioxidant effects from it.
Glutathione demand: Poland vs the US
We compare search demand per head. The index divides Polish searches per million people by US searches per million people; 1.0 means Poles search as often per head as Americans.
| Market | Average monthly searches | Population used | Searches per million people |
|---|---|---|---|
| United States (English name) | 246,000 | 335 million | 734 |
| Poland (Polish name) | 14,800 | 37 million | 400 |
| Index Poland / US | 0.54 |
Source: Google Ads Keyword Planner, average monthly searches, October 2025 - September 2026. Polish figures are for the Polish name searched from Poland, US figures for the English name searched from the US.
Read it with care. 14,800 searches a month is a real audience, and an index of 0.54 puts glutathione just above the line we use for US white spaces (0.5). But search is not sales: some searches are research, and some lead to products bought from outside the EU that a Polish-notified product will compete with on price, not on promises. For the ingredients growing fastest in Polish search, see fastest-growing supplement ingredients in Poland.
Glutathione EU novel food status: what we could confirm
A novel food is "any food that was not used for human consumption to a significant degree within the Union before 15 May 1997" (Regulation (EU) 2015/2283, Art. 3(2)(a)), and "Only novel foods authorised and included in the Union list may be placed on the market within the Union" (Art. 6(2)). For glutathione the form matters: reduced glutathione, S-acetyl glutathione and liposomal preparations are separate questions.
| Check | What we found | Status |
|---|---|---|
| Union list of novel foods as adopted in 2017 | No entry for glutathione in Table 1 (Implementing Regulation (EU) 2017/2470) | Confirmed for the 2017 text; later amendments to be checked in the consolidated Union list |
| S-acetyl glutathione | On the agenda of EFSA's nutrition and novel foods panel, 1-2 July 2026: "Draft opinion on S-Acetyl Glutathione as a novel food" (EFSA NDA Panel agenda) | Treated as a novel food application; an EFSA opinion is not an authorisation. Union list entry to be confirmed |
| Reduced glutathione in the Novel Food Status Catalogue | We could not open the catalogue entry | To be confirmed in the catalogue database |
| Liposomal glutathione | Process and carrier may matter | To be confirmed; see the liposomal section |
The catalogue is "a non-binding tool" that "serves as orientation on whether a product will need an authorisation" (European Commission, Novel Food Status Catalogue); the Polish GIS calls its information indicative (GIS, novel food). The legal duty sits with you: "Food business operators shall verify whether or not the food which they intend to place on the market" falls within the Regulation (Art. 4(1)), and if in doubt they "shall consult the Member State where they first intend to place the novel food" (Art. 4(2)). For Poland that means a consultation with the Polish authority before launch. The general rules are in novel food and maximum doses in Poland.
Liposomal glutathione: format or new process?
Liposomal is the format US brands push hardest for glutathione. Under EU law the question is not only the active ingredient. A novel food can also be "food resulting from a production process not used for food production within the Union before 15 May 1997" where that process significantly changes the food (Regulation (EU) 2015/2283, Art. 3(2)(a)(vii)).
We have not found an official EU or Polish document that classifies liposomal glutathione as such. Treat it as to be confirmed and ask your supplier for:
- The status of the glutathione itself, by form and production method.
- The composition of the liposome: phospholipid source, other carriers, solvents.
- Evidence that the process was used for food in the EU before 15 May 1997, or that it does not significantly change composition or structure.
- Any consultation outcome or authority opinion the supplier relies on, with date and country.
If the answers are thin, use the Art. 4 consultation route before you commit to packaging.
Health claims for glutathione supplements
In the EU, "Health claims shall be prohibited unless" they are authorised and included in the lists of authorised claims (Regulation (EC) No 1924/2006, Art. 10(1)), across "the labelling, presentation or advertising of foods" (Art. 1(2)). We found no entry for glutathione in the annex of Regulation (EU) No 432/2012 in the consolidated version of 17 May 2021 (Regulation (EU) No 432/2012, consolidated). Check the EU Register of health claims for the current position; any later change is to be confirmed.
The common US promises - skin brightening, detox, antioxidant - therefore cannot be made for glutathione in Poland. A route many formulas use is to add a nutrient that has an authorised claim. For example, "Vitamin C contributes to the protection of cells from oxidative stress", usable only for food which is "at least a source of vitamin C" (Regulation (EU) No 432/2012). The claim is then about vitamin C, not glutathione.
- Keep before-and-after skin images out of listings and creator content; they are presentation and advertising too.
- Do not put the promise in the product name ("Detox", "Glow") if the name works as a claim.
- Brief creators with the authorised claims only. See our guide to health claims in Poland and the health claim entry in the Playbook.
Dose practice in Poland
Polish dose practice is set out by the GIS Team for Food Supplements, an advisory body to the Chief Sanitary Inspector that issues opinions as resolutions (GIS, Team for Food Supplements). On 29 October 2026 that page listed no value for glutathione. There is no Polish reference dose to cite, so if the status work above confirms you can sell, the dose has to rest on your supplier's safety data, and on the authorised conditions of use if your form is on the Union list.
Whatever the dose, Directive 2002/46/EC requires the amount of substances with a nutritional or physiological effect to be "declared on the labelling in numerical form" (Art. 8(1)).
Label particulars to plan for
- "the portion of the product recommended for daily consumption" (Directive 2002/46/EC, Art. 6(3)(b)).
- "a warning not to exceed the stated recommended daily dose" (Art. 6(3)(c)).
- The statements that supplements are not a substitute for a varied diet and must be stored out of the reach of young children (Art. 6(3)(d)-(e)).
- For liposomal liquids, the daily portion in millilitres and the glutathione amount in that portion, so the buyer can compare with capsules.
Formats: liposomal, capsules and combinations
| Format | Positioning | Open questions for Poland |
|---|---|---|
| Capsule, reduced glutathione | Simple, closest to the US product | Novel food status of the form; no claim for glutathione |
| Liposomal liquid or softgel | Premium, the main US format | Ingredient status plus liposome process (to be confirmed); shelf life and taste |
| S-acetyl glutathione capsule | Newer form | Under EFSA assessment as a novel food in 2026; needs Union list authorisation before sale |
| Combination with vitamin C | Allows an authorised claim for vitamin C | Vitamin C must meet the "source" condition; check GIS values |
| Powder or effervescent | Lower price per dose | Same status questions; stability of the active |
Run the status check before the format decision, not after. A format that needs novel food authorisation adds a procedure that takes far longer than a packaging change.
How to launch glutathione in Poland: steps
- Name the exact form. Reduced, S-acetyl, liposomal; production method and source.
- Check the Union list and the catalogue. Record the date, the entry and the wording you relied on.
- Consult if unclear. Use the Art. 4(2) consultation route for the Member State of first placing.
- Decide the claim strategy. No glutathione claim; add a nutrient with an authorised claim or sell without claims.
- Write the Polish label. Amount per portion in numbers and the mandatory statements; see label requirements.
- Notify GIS. Before the first sale, with the documents on status and dose ready; see our GIS notification guide and GIS notification.
Sources
Primary legal texts and official pages used in this guide. Always read the consolidated version in force on the day you act.
- Regulation (EU) 2015/2283 on novel foods - EUR-Lex
- Commission Implementing Regulation (EU) 2017/2470, Union list of novel foods (as adopted) - EUR-Lex
- EFSA - NDA Panel, 169th plenary meeting agenda, 1-2 July 2026
- European Commission - Novel Food Status Catalogue
- European Commission - Novel Food Catalogue database (FIP)
- GIS - Nowa żywność (novel food) - gov.pl
- Regulation (EC) No 1924/2006 on nutrition and health claims - EUR-Lex
- Regulation (EU) No 432/2012, consolidated version of 17 May 2021 - EUR-Lex
- GIS - Team for Food Supplements - gov.pl
- Directive 2002/46/EC on food supplements - EUR-Lex
This is not legal advice. Novel food and claims status can change; check the official registers on the day you act.